We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Conor's CoStar Stent Shows Promising Results in EuroSTAR Trial
Conor's CoStar Stent Shows Promising Results in EuroSTAR Trial
May 27, 2005
Follow-up clinical data from Conor Medsystem’s EuroSTAR (EUROpean cobalt chromium STent with Antiproliferative for Restenosis) study demonstrate a low incidence of both target lesion revascularization (TLR) and major adverse cardiac events (MACE), the company announced last week.